Related Experiment Video
Updated: Jan 31, 2026

Transient Expression in Red Beet of a Biopharmaceutical Candidate Vaccine for Type-1 Diabetes
Published on: March 19, 2019
Rotavirus VP6 as a potential vaccine candidate
Atefeh Afchangi1, Somayeh Jalilvand1, Nasir Mohajel2
1Virology Department, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Insights
Group A rotavirus (RVA) causes significant childhood illness and death globally. This review explores the potential of the VP6 protein as a basis for next-generation RVA vaccines, addressing limitations of current options.
Area of Science:
- Virology
- Immunology
- Vaccinology
Background:
- Group A rotavirus (RVA) infection is nearly universal in children by age five, causing substantial global morbidity and mortality.
- Current live attenuated RVA vaccines (Rotarix, RotaTeq) reduce mortality by up to 50% but exhibit reduced efficacy in certain regions.
- The need for more effective RVA vaccines, particularly for developing countries, is critical.
Purpose of the Study:
- To review the characteristics of the VP6 protein of RVA.
- To evaluate the potential of VP6 as a target for developing next-generation RVA vaccines.
- To discuss the immunogenicity and protective capabilities of VP6-based vaccine candidates.
Main Methods:
- Literature review focusing on RVA virology, immunology, and vaccine development.
- Analysis of studies investigating the VP6 protein's antigenic and immunogenic properties.
- Evaluation of research on VP6-based vaccine candidates and their efficacy.
Main Results:
- VP6 is a highly abundant and conserved RVA protein forming the viral capsid's middle layer.
- VP6 elicits both homologous and cross-reactive immune responses, although not typically neutralizing antibodies.
- VP6 preparations have demonstrated partial protection against RVA replication in experimental models.
Conclusions:
- VP6 protein holds promise as a key component for alternative RVA vaccine development.
- Further research into VP6-based vaccines is warranted to overcome limitations of existing RVA vaccines.
- VP6-based strategies may offer a viable path toward improved RVA disease prevention, especially in underperforming regions.
Abstract:
By the age of 5 years, virtually all children have been infected by group A rotavirus (RVA), which is responsible for around half million mortality annually prior to vaccination. Relatively high rate of the morbidity and mortality highlights the necessity of applying preventive procedures particularly in developing countries. Two live attenuated RVA vaccines (Rotarix and RotaTeq) are licensed and now being used in many countries worldwide. Although these vaccines are shown to reduce the mortality up to 50%, several key questions yet remained to answer. Indeed, the licensed RV vaccines were found to be less effective in countries of sub-Saharan Africa and Southeast Asia. Therefore, developing next generation RVA vaccines is warranted. VP6 is highly abundant and conserved protein that forms the middle layer of RV particles and was shown to be both antigenic and immunogenic. Although it does not induce neutralizing antibodies, different VP6 preparations were found to induce homologous and cross-reactive immune responses with partial protection from RVA replication. Although the molecular mechanisms are not fully elucidated, VP6-based RVA vaccine candidates are worthy of further consideration. This review aims to focus on different aspects of VP6 protein and its potentiality for an alternative RV vaccine against RV disease.
Related Concept Videos
Vaccinations
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Potential Energy
Chemical bonds that form attractive forces between atoms also contain potential energy, called chemical energy. When a chemical reaction...
Potential Energy
Standard Electrode Potentials
Cell Potential and Free Energy
Thermodynamics is the branch of physics dealing with the relationship between heat and other forms of energy. In an electrochemical cell, chemical energy is converted into electrical energy.
Thus, a link can be predicted between cell potential, free energy change, and the equilibrium constant for the reaction. Cell potential can also be measured as the oxidant or the reducing strength, and similar acid-base strength measures are reflected in equilibrium...

